Position in MYGN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$407,799
-$31,575 QoQ
Shares Held
90,622
+26.8% QoQ
Ownership
0.096%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MYGN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Quantinno Capital Management LP holds $621,563,254 across 28 Diagnostics & Research names. MYGN ranks #24 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
188,243 | $92,527,081 | |
| 2 | DHR |
Danaher Corp /De/
|
401,864 | $76,193,414 | |
| 3 | ILMN |
Illumina, Inc.
|
617,543 | $76,118,350 | |
| 4 | A |
Agilent Technologies, Inc.
|
527,679 | $60,144,852 | |
| 5 | IDXX |
Idexx Laboratories Inc /De
|
99,794 | $56,073,250 | |
| 6 | DGX |
Quest Diagnostics Inc
|
231,025 | $45,276,279 | |
| 7 | IQV |
Iqvia Holdings Inc.
|
233,974 | $39,901,925 | |
| 8 | CRL |
Charles River Laboratories International, Inc.
|
227,069 | $39,169,402 |
All Filings in MYGN
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $407,799 | 90,622 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $439,374 | 71,443 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $189,368 | 26,192 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $109,412 | 20,605 | Shares | Sole | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||